What Does Ipsen Do?

Total employees6254
HeadquartersBoulogne-Billancourt
Founded

Ipsen is a global biopharmaceutical group focused on innovation and specialty care. The company develops and commercializes innovative medicines in three key therapeutic areas: Oncology, Rare Diseases, and Neuroscience. Ipsen's R&D is focused on its innovative and differentiated technological platforms located in the heart of leading biotechnological and life sciences hubs. With a presence in over 100 countries, Ipsen sells more than 20 drugs and has a direct commercial presence in over 30 countries, aiming to improve patients' lives through innovative therapeutic solutions.

Where Is Ipsen's Headquarters?

HQ Function

Serves as the global corporate center, housing key leadership and overseeing strategic direction, global operations, R&D coordination, financial management, and administrative functions for the company worldwide.

Notable Features:

Modern office facilities designed to promote collaboration and efficiency, located in a dynamic business environment with excellent connectivity to Paris and international transport links.

Work Culture:

Fosters a culture of innovation, collaboration, and patient-centricity. The HQ environment supports cross-functional teamwork and global interaction, reflecting Ipsen's international scope and commitment to scientific excellence.

HQ Significance:

The strategic nerve center for Ipsen, facilitating global decision-making, research and development oversight, and coordination of its international commercial activities. Its location provides access to a rich ecosystem of talent, research institutions, and business partners.

Values Reflected in HQ: The headquarters' design and operations reflect Ipsen's core values of innovation, agility, and a strong focus on delivering results for patients. The collaborative spaces and technological infrastructure underscore its commitment to excellence and teamwork.

Location:

Ipsen operates on a global scale, supporting a wide array of functions across numerous countries. These include research and development in Oncology, Rare Diseases, and Neuroscience; manufacturing and supply chain logistics; commercial operations such as sales, marketing, and market access; as well as medical affairs, regulatory affairs, and corporate support functions. This expansive network enables Ipsen to develop, produce, and deliver its medicines to patients in over 100 countries worldwide.

Street Address:

65 Quai Georges Gorse

City:

Boulogne-Billancourt

State/Province:

Île-de-France

Country:

France

Where Else Does Ipsen Operate Around the World?

Cambridge, MA/USA

Address: 650 East Kendall Street, Cambridge, MA 02142

Serves as Ipsen's primary center for research and development in North America, fostering partnerships with leading academic institutions and biotech companies in the Boston area to advance its pipeline.

Slough, /United Kingdom

Address: 102 Bath Road, Slough, SL1 3XE

Acts as a strategic base for Ipsen's UK and Ireland operations, managing commercialization, medical affairs, and supporting clinical development programs.

Shanghai, /China

Address: Building 1, Lane 500, Chenhui Road, Pudong New Area, Shanghai

Drives Ipsen's growth in the rapidly expanding Chinese healthcare market, tailoring strategies to local needs and collaborating with regional partners to improve patient access to innovative treatments.

Buying Intent Signals for Ipsen

Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.

Notable news
Hiring actively
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
*Example signal, not calculated in real time

Who's Leading Ipsen? Meet the Executive Team

As of April 2025, Ipsen' leadership includes:

David Loew - Chief Executive Officer
Francesco Nuzzolo - Executive Vice President, Chief Financial Officer
Christelle Huguet - Executive Vice President, Head of Research & Development (ad interim)
Steven Hildemann - Executive Vice President, Chief Medical Officer, Head of Global Medical Affairs and Patient Safety
Philippe Lopes-Fernandes - Executive Vice President, Chief Business Officer
Gwenan White - Executive Vice President, Human Resources
Ayisha Gibs - Executive Vice President, Chief Strategy Officer

Who's Investing in Ipsen?

Ipsen has been backed by several prominent investors over the years, including:

Mayroy S.A. (Beaufour family holding company)
Bpifrance Participations SA
Norges Bank Investment Management
The Vanguard Group, Inc.
BlackRock Advisors (UK) Limited

What Leadership Changes Has Ipsen Seen Recently?

Hire1
Exits1

In the past year, Ipsen has experienced key leadership adjustments, including the appointment of a new Chief Financial Officer and an ad interim Head of Research & Development, following the departure of the previous R&D Head. These changes reflect strategic shifts and the company's focus on strengthening its executive team.

Departures

Howard Mayer, Howard Mayer departed from his role as EVP, Head of Research & Development at the end of July 2023.

New Appointments:

Francesco Nuzzolo, Francesco Nuzzolo joined Ipsen as the new Executive Vice President, Chief Financial Officer.
Christelle Huguet, Christelle Huguet was appointed ad interim Executive Vice President, Head of Research & Development.
Ayisha Gibs, Ayisha Gibs transitioned to the role of Executive Vice President, Chief Strategy Officer, after serving as interim CFO.

What Technology (Tech Stack) Is Used byIpsen?

Discover the tools Ipsen uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.

Ipsen Email Formats and Examples

Ipsen predominantly uses the 'firstname.lastname@ipsen.com' email format for its employees. While other formats might exist in specific cases, this is the most common and reliable structure for professional communication.

firstname.lastname@ipsen.com

Format

john.smith@ipsen.com

Example

98%

Success rate

What's the Latest News About Ipsen?

Ipsen Press ReleaseMay 23, 2024

Ipsen Presents New Data for Bylvay® in Alagille Syndrome and PFIC at ESPGHAN 2024

Ipsen announced new efficacy and safety data for Bylvay® (odevixibat) in Alagille syndrome (ALGS) and Progressive Familial Intrahepatic Cholestasis (PFIC), presented at the European Society for Paediatric Gastroenterology, Hepatology and Nutrition (ESPGHAN) Annual Meeting....more

Ipsen Press ReleaseMay 16, 2024

Ipsen Announces Positive Topline Results for Onivyde® Regimen in Second-Line Metastatic Pancreatic Cancer

Ipsen reported positive topline results from the Phase III RESILIENT study evaluating Onivyde® (irinotecan liposome injection) plus 5-fluorouracil/leucovorin and oxaliplatin (NALIRIFOX regimen) in patients with metastatic pancreatic ductal adenocarcinoma (mPDAC) after failure of gemcitabine-based first-line therapy. The study met its primary endpoint of overall survival....more

Ipsen Press ReleaseApril 25, 2024

Ipsen Reports Strong Q1 2024 Performance Driven by Growth Portfolio

Ipsen announced its financial results for the first quarter of 2024, showcasing robust sales growth propelled by its key products in Oncology, Rare Diseases, and Neuroscience. The company also reaffirmed its financial guidance for the full year 2024....more

Highperformr's free tools for company research

Explore Employees by Region or Country

See where a company’s workforce is located, by country or region.

View Funding Details

View past and recent funding rounds with amounts and investors.

Understand Revenue Insights

Understand company revenue estimates and financial scale.

Track Active Job Openings

Track active roles and hiring trends to spot growth signals.

Review Product and Offerings

Discover what a company offers—products, platforms, and solutions.

Get SIC or NAICS Codes

Get the company’s official SIC and NAICS classifications.

Analyze Website Traffic Trends

Analyze visitor volume, engagement, and top traffic sources.

Discover Social Profiles and Engagement

Explore LinkedIn, Twitter, and other active social profiles.

Identify Top Competitors

Identify top competitors based on similar business traits.

Research and Discover Companies with Highperformr — Smarter, Faster

Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.

Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.

  • Track intent signals to find buyers who are actively in-market
  • Enrich contacts and companies instantly, no need to switch tools
  • Automate workflows to stay ahead of every change
  • Connect your CRM & tools for seamless data sync and activation

Thousands of companies, including Ipsen, are just a search away.